Themis Medicare

17
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083B01024
  • NSEID: THEMISMED
  • BSEID: 530199
INR
106.30
0.00 (0.00%)
BSENSE

Dec 05

BSE+NSE Vol: 41.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
405.00
381.00
354.00
394.00
230.00
201.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
405.00
381.00
354.00
394.00
230.00
201.00
Expenditure (Ex Depriciation)
Stock Adjustments
-17.00
-1.00
-7.00
3.00
0.00
-3.00
Raw Materials Consumed
149.00
138.00
126.00
145.00
79.00
66.00
Power & Fuel Cost
11.00
13.00
11.00
12.00
11.00
11.00
Employee Cost
96.00
82.00
66.00
51.00
39.00
44.00
Operating Expenses
20.00
20.00
19.00
23.00
10.00
12.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
31.00
29.00
26.00
26.00
14.00
12.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
26.00
18.00
20.00
18.00
14.00
7.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
356.00
330.00
286.00
298.00
181.00
165.00
Operating Profit (PBDIT) excl Other Income
49.00
51.00
67.00
95.00
49.00
35.00
Other Income
4.00
4.00
11.00
6.00
3.00
3.00
Operating Profit (PBDIT)
53.00
56.00
78.00
102.00
53.00
39.00
Interest
10.00
9.00
9.00
8.00
12.00
12.00
Profit before Depriciation and Tax
43.00
46.00
69.00
93.00
40.00
26.00
Depreciation
9.00
12.00
10.00
9.00
8.00
8.00
Profit Before Taxation & Exceptional Items
33.00
34.00
58.00
83.00
31.00
17.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
39.00
53.00
72.00
95.00
41.00
26.00
Provision for Tax
9.00
9.00
15.00
22.00
5.00
2.00
Profit After Tax
23.00
24.00
43.00
61.00
26.00
15.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
231.00
193.00
140.00
71.00
35.00
10.00
Profit Available for appropriations
261.00
236.00
197.00
144.00
71.00
35.00
Appropriations
261.00
236.00
197.00
144.00
71.00
35.00
Equity Dividend (%)
50.00%
50.00%
50.00%
50.00%
43.00%
17.50%
Earnings Per Share
3.24
4.73
6.18
79.22
38.86
26.97
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 6.22% vs 7.74% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -4.77% vs -23.64% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 7.07% vs -1.96% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -3.28% vs -42.89% in Mar 2024

Compare Profit and Loss Results of Themis Medicare
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
405.00
623.00
-218.00
-34.99%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
405.00
623.00
-218.00
-34.99%
Expenditure (Ex Depriciation)
Stock Adjustments
-17.00
8.00
-25.00
-312.50%
Raw Materials Consumed
149.00
282.00
-133.00
-47.16%
Power & Fuel Cost
11.00
11.00
0.00
0.00%
Employee Cost
96.00
112.00
-16.00
-14.29%
Operating Expenses
20.00
27.00
-7.00
-25.93%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
31.00
28.00
3.00
10.71%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
26.00
3.00
23.00
766.67%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
356.00
521.00
-165.00
-31.67%
Operating Profit (PBDIT) excl Other Income
49.00
101.00
-52.00
-51.49%
Other Income
4.00
22.00
-18.00
-81.82%
Operating Profit (PBDIT)
53.00
123.00
-70.00
-56.91%
Interest
10.00
1.00
9.00
900.00%
Profit before Depriciation and Tax
43.00
122.00
-79.00
-64.75%
Depreciation
9.00
12.00
-3.00
-25.00%
Profit Before Taxation & Exceptional Items
33.00
109.00
-76.00
-69.72%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
39.00
109.00
-70.00
-64.22%
Provision for Tax
9.00
26.00
-17.00
-65.38%
Profit After Tax
23.00
82.00
-59.00
-71.95%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
231.00
507.00
-276.00
-54.44%
Profit Available for appropriations
261.00
589.00
-328.00
-55.69%
Appropriations
261.00
589.00
-328.00
-55.69%
Equity Dividend (%)
50%
18%
32.00
Earnings Per Share
3.24
41.11
-37.87
-92.12%
Profit And Loss - Net Sales
Net Sales 405.51 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 6.22% vs 7.74% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 49.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -4.77% vs -23.64% in Mar 2024

Profit And Loss - Interest
Interest 10.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 7.07% vs -1.96% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 23.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -3.28% vs -42.89% in Mar 2024